ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LEGN Legend Biotech Corporation

42.58
-0.11 (-0.26%)
27 Nov 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Legend Biotech Corporation NASDAQ:LEGN NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.11 -0.26% 42.58 41.63 43.54 43.16 41.80 42.99 1,772,581 01:00:00

Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

20/08/2024 1:00pm

GlobeNewswire Inc.


Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart


From May 2024 to Nov 2024

Click Here for more Legend Biotech Charts.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Wednesday, September 4, 2024, at 2:35 p.m. ET.

The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.

ABOUT LEGEND BIOTECH 

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide. 

Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.

INVESTOR CONTACT: Jessie Yeung Tel: (732) 956-8271  jessie.yeung@legendbiotech.com 

PRESS CONTACT: Mary Ann Ondish Tel: (914) 552-4625 media@legendbiotech.com 

1 Year Legend Biotech Chart

1 Year Legend Biotech Chart

1 Month Legend Biotech Chart

1 Month Legend Biotech Chart

Your Recent History

Delayed Upgrade Clock